West Pharmaceutical Ownership
| WST Stock | USD 225.80 6.10 2.63% |
Shares in Circulation | First Issued 1985-09-30 | Previous Quarter 73.4 M | Current Value 73.7 M | Avarage Shares Outstanding 68 M | Quarterly Volatility 6 M |
West |
West Stock Ownership Analysis
About 97.0% of the company outstanding shares are owned by institutional investors. The company recorded earning per share (EPS) of 6.68. West Pharmaceutical last dividend was issued on the 30th of April 2025. The entity had 2:1 split on the 27th of September 2013. West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania. West Pharmaceutical operates under Medical Instruments Supplies classification in the United States and is traded on New York Stock Exchange. It employs 10065 people. For more information please call Eric Green at 610 594 2900 or visit https://www.westpharma.com.Besides selling stocks to institutional investors, West Pharmaceutical also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different West Pharmaceutical's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align West Pharmaceutical's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
West Pharmaceutical Quarterly Liabilities And Stockholders Equity |
|
West Pharmaceutical Insider Trades History
Less than 1% of West Pharmaceutical Services are currently held by insiders. Unlike West Pharmaceutical's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against West Pharmaceutical's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of West Pharmaceutical's insider trades
West Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as West Pharmaceutical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading West Pharmaceutical Services backward and forwards among themselves. West Pharmaceutical's institutional investor refers to the entity that pools money to purchase West Pharmaceutical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 1 M | Norges Bank | 2024-12-31 | 887.2 K | Findlay Park Partners Llp | 2024-12-31 | 834.7 K | Jpmorgan Chase & Co | 2024-12-31 | 808.7 K | Ubs Asset Mgmt Americas Inc | 2024-12-31 | 790.7 K | Northern Trust Corp | 2024-12-31 | 768.8 K | Amvescap Plc. | 2024-12-31 | 755.2 K | T. Rowe Price Investment Management,inc. | 2024-12-31 | 733.3 K | Van Eck Associates Corporation | 2024-12-31 | 689.5 K | Vanguard Group Inc | 2024-12-31 | 9 M | Blackrock Inc | 2024-12-31 | 7.5 M |
West Pharmaceutical Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific West Pharmaceutical insiders, such as employees or executives, is commonly permitted as long as it does not rely on West Pharmaceutical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases West Pharmaceutical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
West Pharmaceutical's latest congressional trading
Congressional trading in companies like West Pharmaceutical, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in West Pharmaceutical by those in governmental positions are based on the same information available to the general public.
| 2025-03-07 | Representative Jared Moskowitz | Acquired Under $15K | Verify | ||
| 2024-12-09 | Representative Jared Moskowitz | Acquired Under $15K | Verify | ||
| 2024-10-08 | Representative Ro Khanna | Acquired Under $15K | Verify | ||
| 2024-08-21 | Representative Jared Moskowitz | Acquired Under $15K | Verify | ||
| 2022-04-08 | Senator Tommy Tuberville | Acquired Under $15K | Verify |
West Pharmaceutical Outstanding Bonds
West Pharmaceutical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. West Pharmaceutical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most West bonds can be classified according to their maturity, which is the date when West Pharmaceutical Services has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
West Pharmaceutical Corporate Filings
| 21st of March 2025 Other Reports | ViewVerify | |
8K | 11th of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 20th of February 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10K | 18th of February 2025 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for West Stock Analysis
When running West Pharmaceutical's price analysis, check to measure West Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy West Pharmaceutical is operating at the current time. Most of West Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of West Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move West Pharmaceutical's price. Additionally, you may evaluate how the addition of West Pharmaceutical to your portfolios can decrease your overall portfolio volatility.